Johnson & Johnson (NYSE: JNJ) Inc is trading up 0.96% at 159.20 People who got Johnson & Johnson (NYSE: JNJ) Inc’s COVID-19 vaccine as a first shot had a stronger immune response when boosted with vaccines from Pfizer (NYSE: PFE) Inc/BioNTech SE or Moderna (NASDAQ: MRNA) Inc, a study...
Johnson & Johnson (NYSE:JNJ) is trading down 0.57% at 163.81 Johnson & Johnson (NYSE:JNJ) stock traded more than 1% up in Tuesday’s premarket on encouraging results from a phase-III real-world study on a booster dose of its Covid-19 vaccine. The company said its booster shot is 94% effective when...
Johnson & Johnson (NYSE:JNJ) is trading up 0.74% at 165.96 Johnson & Johnson (NYSE:JNJ)stock was trading higher during Friday’s premarket trading as findings from a small lab study indicated that the company’s single dose COVID-19 vaccine may be effective against the Delta variant of the coronavirus. In laboratory testing,...
Johnson & Johnson (NYSE:JNJ) is trading down 0.04% at 165.97 Safety concerns about Johnson & Johnson (NYSE:JNJ)’s COVID-19 vaccine along with overall flagging demand for vaccinations have slowed its U.S. rollout to a crawl, leaving close to half of the 21 million doses produced for the United States sitting...